Artificial intelligence can deliver specialty-level diagnosis in primary care setting, study shows: Results earn first FDA clearance of AI for autonomous detection of diabetic retinopathy

Artificial intelligence can deliver specialty-level diagnosis in primary care setting, study shows: Results earn first FDA clearance of AI for autonomous detection of diabetic retinopathy

A system that uses artificial intelligence (AI) to detect diabetic retinopathy without a person interpreting the results earned Food and Drug Administration (FDA) authorization in April, following a clinical trial in primary care offices. The study was the first to prospectively assess the safety of an autonomous AI system in patient care settings.

  • 0 Likes

  • 0 Comments

You may be interested in

Tell others about your work

128+

Scraps written yesterday

Your works only be popular when others learn about your work.

Terms . Privacy . Help . Newsroom . Contact Us

MachPrinciple © 2020